|
1
|
Li H, Bai S, Ao Q, Wang X, Tian X, Li X,
Tong H, Hou W and Fan J: Modulation of immune-inflammatory
responses in abdominal aortic aneurysm: Emerging molecular targets.
J Immunol Res. 2018.7213760:2018.
|
|
2
|
Keisler B and Carter C: Abdominal aortic
aneurysm. Am Fam Physician. 91:538–543. 2015.PubMed/NCBI
|
|
3
|
Altobelli E, Rapacchietta L, Profeta VF
and Fagnano R: Risk factors for abdominal aortic aneurysm in
population-based studies: A systematic review and meta-analysis.
Int J Environ Res Public Health. 15:28052018. View Article : Google Scholar
|
|
4
|
Tchana-Sato V, Sakalihasan N and Defraigne
JO: Ruptured abdominal aortic aneurysm. Rev Med Liege. 73:296–299.
2018.In French. PubMed/NCBI
|
|
5
|
Joviliano EE, Ribeiro MS and Tenorio EJR:
MicroRNAs and current concepts on the pathogenesis of abdominal
aortic aneurysm. Braz J Cardiovasc Surg. 32:215–224.
2017.PubMed/NCBI
|
|
6
|
Wang YD, Liu ZJ, Ren J and Xiang MX:
Pharmacological therapy of abdominal aortic aneurysm: An update.
Curr Vasc Pharmacol. 16:114–124. 2018. View Article : Google Scholar
|
|
7
|
Jiang L, Hu M, Lu Y, Cao Y, Chang Y and
Dai Z: The protective effects of dexmedetomidine on ischemic brain
injury: A meta-analysis. J Clin Anesth. 40:25–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou SZ, Li ZM, Liu XR, Zhou J, Tan XQ,
Yang Y and Wei JC: Bidirectional regulatory effects of
dexmedetomidine on porcine coronary tone in vitro. Med Sci Monit.
23:1621–1626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soliman R and Zohry G: The myocardial
protective effect of dexmedetomidine in high-risk patients
undergoing aortic vascular surgery. Ann Card Anaesth. 19:606–613.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bao Y, Zhu Y, He G, Ni H, Liu C, Ma L,
Zhang L and Shi D: Dexmedetomidine attenuates neuroinflammation in
LPS-stimulated BV2 microglia cells through upregulation of miR-340.
Drug Des Devel Ther. 13:3465–3475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Essandoh K, Li Y, Huo J and Fan GC:
MiRNA-Mediated macrophage polarization and its potential role in
the regulation of inflammatory response. Shock. 46:122–131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sheedy FJ: Turning 21: Induction of miR-21
as a key switch in the inflammatory response. Front Immunol.
6:192015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bekelis K, Kerley-Hamilton JS, Teegarden
A, Tomlinson CR, Kuintzle R, Simmons N, Singer RJ, Roberts DW,
Kellis M and Hendrix DA: MicroRNA and gene expression changes in
unruptured human cerebral aneurysms. J Neurosurg. 125:1390–1399.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adam M, Raaz U, Spin JM and Tsao PS:
MicroRNAs in abdominal aortic aneurysm. Curr Vasc Pharmacol.
13:280–290. 2015. View Article : Google Scholar
|
|
15
|
Maegdefessel L, Azuma J, Toh R, Deng A,
Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell
MV, et al: MicroRNA-21 blocks abdominal aortic aneurysm development
and nicotine-augmented expansion. Sci Transl Med. 4:pp.
122ra1222012, View Article : Google Scholar
|
|
16
|
Zhang J, Zhang M, Yang Z, Huang S, Wu X,
Cao L, Wang X, Li Q, Li N and Gao F: PDCD4 deficiency ameliorates
left ventricular remodeling and insulin resistance in a rat model
of type 2 diabetic cardiomyopathy. BMJ Open Diabetes Res Care.
8:pp. e0010812020, View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He J, Yue Y, Dong C and Xiong S: MiR-21
confers resistance against CVB3-induced myocarditis by inhibiting
PDCD4-mediated apoptosis. Clin Invest Med. 36:E103–E111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang K, Pan X, Zheng J, Liu Y and Sun L:
SIRT1 protects against aortic dissection by regulating AP-1/decorin
signaling-mediated PDCD4 activation. Mol Biol Rep. 47:2149–2159.
2020PubMed/NCBI
|
|
19
|
Tanaka A, Hasegawa T, Chen Z, Okita Y and
Okada K: A novel rat model of abdominal aortic aneurysm using a
combination of intraluminal elastase infusion and extraluminal
calcium chloride exposure. J Vasc Surg. 50:1423–1432. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du C, Hu R, Csernansky CA, Hsu CY and Choi
DW: Very delayed infarction after mild focal cerebral ischemia: A
role for apoptosis? J Cereb Blood Flow Metab. 16:195–201. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeon AR and Kim JE: PDI knockdown inhibits
seizure activity in acute seizure and chronic epilepsy rat models
via S-nitrosylation-independent thiolation on NMDA receptor. Front
Cell Neurosci. 12:4382018. View Article : Google Scholar :
|
|
22
|
Lai CH, Chang JY, Wang KC, Lee FT, Wu HL
and Cheng TL: Pharmacological inhibition of cathepsin S suppresses
abdominal aortic aneurysm in mice. Eur J Vasc Endovasc Surg.
59:990–999. 2020PubMed/NCBI
|
|
23
|
Zhang Y, Yuan H, Bu P, Shen YH, Liu T,
Song S and Hou X: Recombinant leptin attenuates abdominal aortic
aneurysm formation in angiotensin II-infused apolipoprotein
E-deficient mice. Biochem Biophys Res Commun. 503:1450–1456. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chi X, Wei X, Gao W, Guan J, Yu X, Wang Y,
Li X and Cai J: Dexmedetomidine ameliorates acute lung injury
following orthotopic autologous liver transplantation in rats
probably by inhibiting toll-like receptor 4-nuclear factor kappa B
signaling. J Transl Med. 13:1902015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zampetaki A, Attia R, Mayr U, Gomes RS,
Phinikaridou A, Yin X, Langley SR, Willeit P, Lu R, Fanshawe B, et
al: Role of miR-195 in aortic aneurysmal disease. Circ Res.
115:857–866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li P, Yin YL, Guo T, Sun XY, Ma H, Zhu ML,
Zhao FR, Xu P, Chen Y, Wan GR, et al: Inhibition of aberrant
microRNA-133a expression in endothelial cells by statin prevents
endothelial dysfunction by targeting GTP cyclohydrolase 1 in vivo.
Circulation. 134:1752–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN
and Lin X: Hepatitis B virus X protein induces hepatic steatosis by
enhancing the expression of liver fatty acid binding protein. J
Virol. 90:1729–1740. 2016. View Article : Google Scholar :
|
|
28
|
Setozaki S, Minakata K, Masumoto H, Hirao
S, Yamazaki K, Kuwahara K, Ikeda T and Sakata R: Prevention of
abdominal aortic aneurysm progression by oral administration of
green tea polyphenol in a rat model. J Vasc Surg. 65:1803–1812.
2017. View Article : Google Scholar
|
|
29
|
Zatroch KK, Knight CG, Reimer JN and Pang
DS: Refinement of intraperitoneal injection of sodium pentobarbital
for euthanasia in laboratory rats (Rattus norvegicus). BMC Vet Res.
13:602017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maegdefessel L, Spin JM, Raaz U, Eken SM,
Toh R, Azuma J, Adam M, Nakagami F, Heymann HM, Chernogubova E, et
al: miR-24 limits aortic vascular inflammation and murine abdominal
aneurysm development. Nat Commun. 5:52142014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurobe H, Matsuoka Y, Hirata Y, Sugasawa
N, Maxfield MW, Sata M and Kitagawa T: Azelnidipine suppresses the
progression of aortic aneurysm in wild mice model through
anti-inflammatory effects. J Thorac Cardiovasc Surg. 146:1501–1508.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Stather PW, Sylvius N, Sidloff DA, Dattani
N, Verissimo A, Wild JB, Butt HZ, Choke E, Sayers RD and Bown MJ:
Identification of microRNAs associated with abdominal aortic
aneurysms and peripheral arterial disease. Br J Surg. 102:755–766.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakalihasan N, Michel JB, Katsargyris A,
Kuivaniemi H, Defraigne JO, Nchimi A, Powell JT, Yoshimura K and
Hultgren R: Abdominal aortic aneurysms. Nat Rev Dis Primers.
4:342018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, Wang H, Dong B, Ma J and Wu X:
Adding dexmedetomidine to ropivacaine for femoral nerve block
inhibits local inflammatory response. Minerva Anestesiol.
83:590–597. 2017.PubMed/NCBI
|
|
36
|
Vandenbroucke RE and Libert C: Is there
new hope for therapeutic matrix metalloproteinase inhibition? Nat
Rev Drug Discov. 13:904–927. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rabkin SW: The role matrix
metalloproteinases in the production of aortic aneurysm. Prog Mol
Biol Transl Sci. 147:239–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duellman T, Warren CL, Peissig P, Wynn M
and Yang J: Matrix metalloproteinase-9 genotype as a potential
genetic marker for abdominal aortic aneurysm. Circ Cardiovasc
Genet. 5:529–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Chen Q, He X, Alam A, Ning J, Yi B,
Lu K and Gu J: Dexmedetomidine attenuates lung apoptosis induced by
renal ischemia-reperfusion injury through α2AR/PI3K/akt
pathway. J Transl Med. 16:782018. View Article : Google Scholar
|
|
40
|
Bianconi V, Sahebkar A, Atkin SL and Pirro
M: The regulation and importance of monocyte chemoattractant
protein-1. Curr Opin Hematol. 25:44–51. 2018. View Article : Google Scholar
|
|
41
|
Liu H, Davis JR, Wu ZL and Abdelgawad AF:
Dexmedetomidine attenuates lipopolysaccharide induced MCP-1
expression in primary astrocyte. Biomed Res Int.
2017.6352159:2017.
|
|
42
|
Sun Y, Jiang C, Jiang J and Qiu L:
Dexmedetomidine protects mice against myocardium
ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS
pathway. Clin Exp Pharmacol Physiol. 44:946–953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kin K, Miyagawa S, Fukushima S, Shirakawa
Y, Torikai K, Shimamura K, Daimon T, Kawahara Y, Kuratani T and
Sawa Y: Tissue- and plasma-specific MicroRNA signatures for
atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc. 1:pp.
e0007452012, View Article : Google Scholar
|
|
44
|
Yang L, Wang B, Zhou Q, Wang Y, Liu X, Liu
Z and Zhan Z: MicroRNA-21 prevents excessive inflammation and
cardiac dysfunction after myocardial infarction through targeting
KBTBD7. Cell Death Dis. 9:7692018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mitchell JP and Carmody RJ: NF-κB and the
transcriptional control of inflammation. Int Rev Cell Mol Biol.
335:41–84. 2018. View Article : Google Scholar
|
|
46
|
Liu YF, Bai YQ and Qi M: Daidzein
attenuates abdominal aortic aneurysm through NF-κB, p38MAPK and
TGF-β1 pathways. Mol Med Rep. 14:955–962. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Barnett RE, Conklin DJ, Ryan L, Keskey RC,
Ramjee V, Sepulveda EA, Srivastava S, Bhatnagar A and Cheadle WG:
Anti-Inflammatory effects of miR-21 in the macrophage response to
peritonitis. J Leukoc Biol. 99:361–371. 2016. View Article : Google Scholar
|
|
48
|
Xu H, Cao H, Zhu G, Liu S and Li H:
Overexpression of microRNA-145 protects against rat myocardial
infarction through targeting PDCD4. Am J Transl Res. 9:5003–5011.
2017.PubMed/NCBI
|
|
49
|
Liu K, Liu C and Zhang Z: lncRNA GAS5 acts
as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation
and migration in vascular smooth muscle cells. J Cell Biochem.
120:15233–15240. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhu Y, Liu L, Hu L, Dong W, Zhang M, Liu Y
and Li P: Effect of celastrus orbiculatus in inhibiting
helicobacter pylori induced inflammatory response by regulating
epithelial mesenchymal transition and targeting miR-21/PDCD4
signaling pathway in gastric epithelial cells. BMC Complement
Altern Med. 19:912019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang L, Jiang Y, Song X, Guo C, Zhu F,
Wang X, Wang Q, Shi Y, Wang J, Gao F, et al: Pdcd4 deficiency
enhances macrophage lipoautophagy and attenuates foam cell
formation and atherosclerosis in mice. Cell Death Dis. 7:pp.
e20552016, View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liang X, Xu Z, Yuan M, Zhang Y, Zhao B,
Wang J, Zhang A and Li G: MicroRNA-16 suppresses the activation of
inflammatory macrophages in atherosclerosis by targeting PDCD4. Int
J Mol Med. 37:967–975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Su Q, Li L, Zhao J, Sun Y and Yang H:
Effects of trimetazidine on PDCD4/NF-κB/TNF-α pathway in coronary
microembolization. Cell Physiol Biochem. 42:753–760. 2017.
View Article : Google Scholar
|
|
54
|
Su Q, Li L, Liu Y, Zhou Y, Wang J and Wen
W: Ultrasound-Targeted microbubble destruction-mediated microRNA-21
transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent
coronary microembolization-induced cardiac dysfunction. Gene Ther.
22:1000–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen Z, Ding T and Ma CG: Dexmedetomidine
(DEX) protects against hepatic ischemia/reperfusion (I/R) injury by
suppressing inflammation and oxidative stress in NLRC5 deficient
mice. Biochem Biophys Res Commun. 493:1143–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
